PBH — Prestige Consumer Healthcare Income Statement
0.000.00%
Last trade - 00:00
- $3.46bn
- $4.60bn
- $1.13bn
- 92
- 46
- 91
- 90
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 976 | 963 | 943 | 1,087 | 1,128 |
Cost of Revenue | |||||
Gross Profit | 556 | 561 | 547 | 621 | 625 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 908 | 674 | 658 | 759 | 1,150 |
Operating Profit | 67.5 | 289 | 285 | 328 | -22.4 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -38.1 | 191 | 204 | 262 | -93.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | -35.8 | 142 | 165 | 205 | -82.3 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -35.8 | 142 | 165 | 205 | -82.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -35.8 | 142 | 165 | 205 | -82.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.23 | 2.94 | 3.45 | 4.08 | 3.24 |